Cargando…

Tocilizumab: Intrauterine fetal demise following off-label treatment: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948028/ http://dx.doi.org/10.1007/s40278-022-12329-z

Ejemplares similares

Intraplacental Leiomyoma in a Case of Second-Trimester Intrauterine Fetal Demise
por: Koo, Selene C, et al.
Publicado: (2020)

Partial molar pregnancy with hydrops fetalis causing intrauterine fetal demise: A case report
por: Panthi, Anup, et al.
Publicado: (2023)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021)

Educational Case: Intrauterine Fetal Demise and Intestinal Atresia: An Autopsy Investigation
por: Kuan, Kevin, et al.
Publicado: (2020)

Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022)

Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)

Tocilizumab: Lobar pneumonia following off label use: case report
Publicado: (2020)

Tocilizumab: Bacterial superinfection following off-label use: case report
Publicado: (2020)

Tocilizumab: Anastomotic leakage following off label use: case report
Publicado: (2021)

Tocilizumab: Active tuberculosis following off label use: case report
Publicado: (2021)

Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Poor Dental Hygiene in Pregnancy Leading to Submandibular Cellulitis and Intrauterine Fetal Demise: Case Report and Literature Review
por: Mukherjee, Soma, et al.
Publicado: (2013)

Intrapartum Intrauterine Fetal Demise with Normal Umbilical Cord Blood Gas Values at Birth
por: Benson, Michael D.
Publicado: (2015)

To Clot or Not: HELLP Syndrome and Disseminated Intravascular Coagulation in an Eclamptic Patient with Intrauterine Fetal Demise
por: Walker, Justin, et al.
Publicado: (2020)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Tocilizumab: Herpes zoster infection following an off label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Tocilizumab: Decrease in WBC count following an off-label use: case report
Publicado: (2020)

Tocilizumab: Progression of multiple myeloma following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Tocilizumab: Bowel perforation following off-label use: 2 case reports
Publicado: (2021)

Tocilizumab: Various toxicities following off label use: 4 case reports
Publicado: (2021)

Intrauterine Fetal Demise After Uncomplicated COVID-19: What Can We Learn from the Case?
por: Babal, Pavel, et al.
Publicado: (2021)

Intrauterine fetal demise as a result of maternal COVID-19 infection in the third trimester of pregnancy: A case report
por: Gant, Tayler F., et al.
Publicado: (2022)

Neglected intrauterine fetal demise for more than two decades leading to the development of a lithopedion: a case report
por: Gebresenbet, Fitsum Fikru, et al.
Publicado: (2019)

Tocilizumab: Posterior reversible encephalopathy syndrome following off-label treatment: 4 case reports
Publicado: (2021)

Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Publicado: (2020)

Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Lopinavir/ritonavir/tocilizumab: Hypertriglyceridaemia following off-label use: 2 case reports
Publicado: (2020)

Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020)

Tocilizumab: Elevated AST and ALT following off label therapy: 11 case reports
Publicado: (2021)

Chloroquine/tocilizumab: Leucopenia and liver injury following off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_alk4p3jlem4en5f1ric7g6vrmb